Literature DB >> 3174019

Perisilicone proliferation after vitrectomy for proliferative vitreoretinopathy.

H Lewis1, J M Burke, G W Abrams, T M Aaberg.   

Abstract

From 1983 to 1986, silicone oil injections were used to treat 31 patients with retinal detachment (RD) and advanced proliferative vitreoretinopathy (PVR). In 19 eyes (61%), perisilicone proliferation (PSP) developed causing recurrent RDs in 15 eyes (49%). At an average of 5 weeks after surgery, PSP occurred and was characterized by extensive transparent preretinal membranes with denser focal areas. Microscopic examination of five preretinal membranes showed droplets of silicone oil and necrotic cells on the silicone side and glial or retinal pigment epithelial cells, or both, on the retinal side, often in layers separated by extracellular matrix. Silicone oil was present in periretinal membranes removed several months after the intraocular silicone had been evacuated indicating that silicone within cells may persist despite the removal of silicone. The use of silicone oil to provide tamponade in eyes with recurrent PVR is associated with a high incidence of periretinal proliferation that frequently leads to recurrent RD and visual failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3174019     DOI: 10.1016/s0161-6420(88)33136-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  26 in total

1.  Immunopathology of intraocular silicone oil: retina and epiretinal membranes.

Authors:  Louisa J Wickham; Riaz H Asaria; Robert Alexander; Phil Luthert; David G Charteris
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

2.  Vitreous Substitutes.

Authors:  William Joseph Foster
Journal:  Expert Rev Ophthalmol       Date:  2008-04

3.  The use of silicone oil-RMN3 (Oxane HD) as heavier-than-water internal tamponade in complicated inferior retinal detachment surgery.

Authors:  Louisa Wickham; Paris Tranos; Paul Hiscott; David Charteris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-27       Impact factor: 3.117

Review 4.  [Artificial vitreous body: Strategies for vitreous body substitutes].

Authors:  S Mariacher; P Szurman
Journal:  Ophthalmologe       Date:  2015-07       Impact factor: 1.059

5.  Intravitreal silicone oil injection: complications and treatment of 415 consecutive patients.

Authors:  K G Riedel; V P Gabel; L Neubauer; A Kampik; O E Lund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

6.  Temporary silicone oil tamponade in the treatment of complicated diabetic retinal detachments.

Authors:  M Gonvers
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 7.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

8.  A quality of life survey in patients with long-term silicone oil or phthisis bulbi.

Authors:  Jennifer Doyle; Yunfei Yang; Jonathan H Norris; Sher A Aslam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-03-12       Impact factor: 3.117

9.  Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid.

Authors:  R H Y Asaria; C H Kon; C Bunce; C S Sethi; G A Limb; P T Khaw; G W Aylward; D G Charteris
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

10.  Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment.

Authors:  F Bottoni; M Sborgia; P Arpa; N De Casa; E Bertazzi; M Monticelli; V De Molfetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.